Clinical trial
The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With…
NCT00133042 · University of Florida, Other · Completed
Key facts
| NCT number | NCT00133042 |
|---|---|
| Title | The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma |
| Lead sponsor | University of Florida, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | omalizumab |
| Enrollment | 16 |
| Start date | Dec 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Aug 22, 2005 |
| Last update posted | Sep 20, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: